Gene-gene interaction of μ-opioid receptor and GluR5 kainate receptor subunit is associated with smoking behavior in a Greek population: presence of a dose allele effect

References

1. Cheng LS, Swan GE, Carmelli D. A genetic analysis of smoking behavior in family members of older adult males. Addiction 2000;95:427–35.10.1046/j.1360-0443.2000.95342713.xSuche in Google Scholar

2. Davies GE, Soundy TJ. The genetics of smoking and nicotine addiction. S D Med 2009;Spec No:43–9.Suche in Google Scholar

3. Ho MK, Tyndale RF. Overview of the pharmacogenomics of cigarette smoking. Pharmacogenomics J 2007;7:81–98.10.1038/sj.tpj.6500436Suche in Google Scholar

4. Iordanidou M, Tavridou A, Petridis I, Kyroglou S, Kaklamanis L, Christakidis D, et al. Association of polymorphisms of the serotonergic system with smoking initiation in Caucasians. Drug Alcohol Depend 2010;108:70–6.10.1016/j.drugalcdep.2009.11.015Suche in Google Scholar

5. Ragia G, Iordanidou M, Giannakopoulou E, Tavridou A, Manolopoulos VG. Association of DRD2 TaqIA and DβH -1021C>T Gene Polymorphisms with Smoking Initiation and their Interaction with Serotonergic System Gene Polymorphisms. Curr Pharmacogenomics Person Med 2013;11:110–7.10.2174/1875692111311020004Suche in Google Scholar

6. Marty MA, Erwin VG, Cornell K, Zgombick JM. Effects of nicotine on beta-endorphin, alpha MSH, and ACTH secretion by isolated perfused mouse brains and pituitary glands, in vitro. Pharmacol Biochem Behav 1985;22:317–25.10.1016/0091-3057(85)90397-1Suche in Google Scholar

7. Hadjiconstantinou M, Neff NH. Nicotine and endogenous opioids: neurochemical and pharmacological evidence. Neuropharmacology 2011;60:1209–20.10.1016/j.neuropharm.2010.11.010Suche in Google Scholar

8. Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L, et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA 1998;95:9608–13.10.1073/pnas.95.16.9608Suche in Google Scholar

9. D’Souza MS, Markou A. The “stop” and “go” of nicotine dependence: role of GABA and glutamate. Cold Spring Harb Perspect Med 2013;3:a012146.10.1101/cshperspect.a012146Suche in Google Scholar

10. Mansvelder HD, Keath JR, McGehee DS. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 2002;33:905–19.10.1016/S0896-6273(02)00625-6Suche in Google Scholar

11. Mao D, McGehee DS. Nicotine and behavioral sensitization. J Mol Neurosci 2010;40:154–63.10.1007/s12031-009-9230-7Suche in Google Scholar PubMed

12. Kranzler HR, Gelernter J, Anton RF, Arias AJ, Herman A, Zhao H, et al. Association of markers in the 3’ region of the GluR5 kainate receptor subunit gene to alcohol dependence. Alcohol Clin Exp Res 2009;33:925–30.10.1111/j.1530-0277.2009.00913.xSuche in Google Scholar PubMed PubMed Central

13. Uhl GR, Liu QR, Drgon T, Johnson C, Walther D, Rose JE, et al. Molecular genetics of successful smoking cessation: convergent genome-wide association study results. Arch Gen Psychiatry 2008;65:683–93.10.1001/archpsyc.65.6.683Suche in Google Scholar PubMed PubMed Central

14. Shinn HK, Kim TJ, Lee HS, Kang JU, Han JU, Lim HK, et al. The correlation between genetic polymorphism of OPRM1 (A118G) and MDR1 (C3435T) with analgesia and the adverse effects by epidural morphine. Korean J Anesthesiol 2007;52:16–22.10.4097/kjae.2007.52.1.16Suche in Google Scholar

15. dbSNP. OPRM1 rs1799971A>G http://wwwncbinlmnihgov/projects/SNP/snp_refcgi?rs=1799971.Suche in Google Scholar

16. dbSNP. GRIK1 rs2832407C>A http://wwwncbinlmnihgov/projects/SNP/snp_refcgi?rs=2832407.Suche in Google Scholar

17. Kranzler HR, Armeli S, Covault J, Tennen H. Variation in OPRM1 moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment. Addict Biol 2012;18:193–201.10.1111/j.1369-1600.2012.00471.xSuche in Google Scholar PubMed PubMed Central

18. Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR, et al. A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 2003;28:1546–52.10.1038/sj.npp.1300219Suche in Google Scholar PubMed

19. Gelernter J, Gueorguieva R, Kranzler HR, Zhang H, Cramer J, Rosenheck R, et al. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study. Alcohol Clin Exp Res 2007;31:555–63.10.1111/j.1530-0277.2007.00339.xSuche in Google Scholar PubMed

20. Anton RF, Oroszi G, O’Malley S, Couper D, Swift R, Pettinati H, et al. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry 2008;65:135–44.10.1001/archpsyc.65.2.135Suche in Google Scholar PubMed PubMed Central

21. Kranzler HR, Covault J, Feinn R, Armeli S, Tennen H, Arias AJ, et al. Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism. Am J Psychiatry 2014;171:445–52.10.1176/appi.ajp.2013.13081014Suche in Google Scholar PubMed PubMed Central

22. Ray LA, Miranda R, Jr., MacKillop J, McGeary J, Tidey JW, Rohsenow DJ, et al. A preliminary pharmacogenetic investigation of adverse events from topiramate in heavy drinkers. Exp Clin Psychopharmacol 2009;17:122–9.10.1037/a0015700Suche in Google Scholar PubMed PubMed Central

23. Ray LA, Barr CS, Blendy JA, Oslin D, Goldman D, Anton RF. The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review. Alcohol Clin Exp Res 2012;36:385–94.10.1111/j.1530-0277.2011.01633.xSuche in Google Scholar PubMed PubMed Central

24. Sturgess JE, George TP, Kennedy JL, Heinz A, Muller DJ. Pharmacogenetics of alcohol, nicotine and drug addiction treatments. Addict Biol 2011;16:357–76.10.1111/j.1369-1600.2010.00287.xSuche in Google Scholar PubMed

25. Mura E, Govoni S, Racchi M, Carossa V, Ranzani GN, Allegri M, et al. Consequences of the 118A>G polymorphism in the OPRM1 gene: translation from bench to bedside? J Pain Res 2013;6:331–53.10.2147/JPR.S42040Suche in Google Scholar PubMed PubMed Central

26. Ragia G, Manolopoulos VG. Pharmacogenomics of Alcohol addiction: personalizing pharmacologic treatment of alcohol dependence. Hospital Pharmacology 2014;1:147–67.10.5937/hpimj1403147RSuche in Google Scholar

27. Verhagen M, Kleinjan M, Engels RC. A systematic review of the A118G (Asn40Asp) variant of OPRM1 in relation to smoking initiation, nicotine dependence and smoking cessation. Pharmacogenomics 2012;13:917–33.10.2217/pgs.12.76Suche in Google Scholar PubMed

28. Schuck K, Otten R, Engels RC, Kleinjan M. Initial responses to the first dose of nicotine in novel smokers: the role of exposure to environmental smoking and genetic predisposition. Psychol Health 2014;29:698–716.10.1080/08870446.2014.884222Suche in Google Scholar PubMed

29. Domino EF, Evans CL, Ni L, Guthrie SK, Koeppe RA, Zubieta JK. Tobacco smoking produces greater striatal dopamine release in G-allele carriers with mu opioid receptor A118G polymorphism. Prog Neuropsychopharmacol Biol Psychiatry 2012;38:236–40.10.1016/j.pnpbp.2012.04.003Suche in Google Scholar PubMed

30. Oncken C, Arias AJ, Feinn R, Litt M, Covault J, Sofuoglu M, et al. Topiramate for smoking cessation: a randomized, placebo-controlled pilot study. Nicotine Tob Res 2014;16:288–96.10.1093/ntr/ntt141Suche in Google Scholar PubMed PubMed Central

31. Centers for Disease Control and Prevention: Smoking and Diabetes. http://wwwcdcgov/tobacco/campaign/tips/diseases/diabeteshtml. Accessed on 3 Feb 2015.Suche in Google Scholar

32. U.S. Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: US. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014.Suche in Google Scholar